![Daniel Tillett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 38 M $ al 31/05/2026
Dr. Daniel Tillett is a Chief Executive Officer, MD & Director at Racura Oncology Ltd. He is on the Board of Directors at Entropy Neurodynamics Ltd. and Racura Oncology Ltd. Dr. Tillett was previously employed as a Non-Executive Director by Simble Solutions Ltd., an Executive Director & Chief Scientific Officer by Race Oncology Ltd., and a Chief Executive Officer by Nucleics Ltd. He received his undergraduate degree from School of Biotechnology & Biomolecular Sciences and a doctorate degree from School of Biotechnology & Biomolecular Sciences.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RACURA ONCOLOGY LTD 10,64 % | 28/05/2026 | 20.269.351 ( 10,64 % ) | 38 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RACURA ONCOLOGY LTD | Director Ejecutivo | 22/11/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Director/Miembro de la Junta | 03/07/2023 |
| RACURA ONCOLOGY LTD | Director Técnico/Científico/I+D | 23/03/2023 |
Nucleics Ltd. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Simble Solutions Ltd.
 Simble Solutions Ltd. Packaged SoftwareTechnology Services Develops software for enterprises to manage business and resources | Technology Services |
School of Biotechnology & Biomolecular Sciences
 School of Biotechnology & Biomolecular Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleics Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
